Literature DB >> 2793260

Infective endocarditis following patch closure of ventricular septal defect: a cross-sectional Doppler echocardiographic study.

S Shrivastava1, S Radhakrishnan.   

Abstract

Cross-sectional and Doppler echocardiographic characteristics of infective endocarditis are described in six cases following patch closure of a ventricular septal defect. The patients presented to us with fever one to five months after surgery. Five of them also had congestive cardiac failure. Cross-sectional echocardiography showed large masses over the patch in all cases. Dehiscence of the lower end of the patch was identified in three of them, and, in two cases, the right sinus of Valsalva had ruptured into the right ventricle. Doppler detected turbulent flow in the right ventricle in five cases, and a continuous signal indicating an aorto-right ventricular communication in two cases. A signal indicative of aortic regurgitation was also found in the latter two cases. Staphylococcus aureus was cultured from the blood in three cases and Aspergillus was identified at autopsy in one. The echocardiographic findings were confirmed in three cases (one during surgery and two at autopsy). Dehiscence of the patch and large masses were associated with a poor prognosis.

Entities:  

Mesh:

Year:  1989        PMID: 2793260     DOI: 10.1016/0167-5273(89)90158-7

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Reoperation for prosthetic ventricular septal defect patch endocarditis: long-term results with an autologous atrial septal patch.

Authors:  Takako Miyazaki; Masaaki Yamagishi; Hitoshi Yaku
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-11-15

2.  Methicillin-resistant Staphylococcus aureus endocarditis following patch closure of a ventricular septal defect: report of a case.

Authors:  S Aoyagi; T Kawara; T Mizoguchi; F Ando; T Yanai; E Yamamoto; K Suzuki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.